UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 139

Sortiert nach

PI3K/Akt/mTOR inhibitors in breast cancer

Cancer biology & medicine, 2015-12, Vol.12 (4), p.342-354

2015

Link zum Volltext

Verfügbarkeit prüfen

Overall Survival with Ribociclib plus Letrozole in Advanced Breast Cancer

The New England journal of medicine, 2022-03, Vol.386 (10), p.942-950

2022

Link zum Volltext

Verfügbarkeit prüfen

Ribociclib, a CDK 4/6 inhibitor, plus endocrine therapy in Asian women with advanced breast cancer

Cancer science, 2020-09, Vol.111 (9), p.3313-3326

2020

Link zum Volltext

Verfügbarkeit prüfen

HER2 expression, copy number variation and survival outcomes in HER2-low non-metastatic breast cancer: an international multicentre cohort study and TCGA-METABRIC analysis

BMC medicine, 2022-03, Vol.20 (1), p.105-105, Article 105

2022

Link zum Volltext

Verfügbarkeit prüfen

Potential value of ctDNA monitoring in metastatic HR + /HER2 - breast cancer: longitudinal ctDNA analysis in the phase Ib MONALEESASIA trial

BMC medicine, 2023-08, Vol.21 (1), p.306-306, Article 306

2023

Link zum Volltext

Verfügbarkeit prüfen

Tissue-specific cell-free DNA degradation quantifies circulating tumor DNA burden

Nature communications, 2021-04, Vol.12 (1), p.2229-2229, Article 2229

2021

Link zum Volltext

Verfügbarkeit prüfen

Classification of HER2-negative breast cancers by ERBB2 copy number alteration status reveals molecular differences associated with chromosome 17 gene aberrations

Therapeutic advances in medical oncology, 2023-01, Vol.15, p.17588359231206259-17588359231206259

2023

Link zum Volltext

Verfügbarkeit prüfen

Low-dose anti-inflammatory combinatorial therapy reduced cancer stem cell formation in patient-derived preclinical models for tumour relapse prevention

British journal of cancer, 2019-02, Vol.120 (4), p.407-423

2019

Link zum Volltext

Verfügbarkeit prüfen

Detection and prognostic relevance of circulating tumour cells (CTCs) in Asian breast cancers using a label-free microfluidic platform

PloS one, 2019-09, Vol.14 (9), p.e0221305-e0221305

2019

Link zum Volltext

Verfügbarkeit prüfen

Impact of deviation from guideline recommended treatment on breast cancer survival in Asia

Scientific reports, 2020-01, Vol.10 (1), p.1330-1330, Article 1330

2020

Link zum Volltext

Verfügbarkeit prüfen

An Overview of the Treatment Efficacy and Side Effect Profile of Pharmacological Therapies in Asian Patients with Breast Cancer

Targeted oncology, 2021-11, Vol.16 (6), p.701-741

2021

Link zum Volltext

Verfügbarkeit prüfen

Regulatory and operational challenges in conducting Asian International Academic Trial for expanding the indications of cancer drugs

Clinical and translational science, 2021-05, Vol.14 (3), p.1015-1025

2021

Link zum Volltext

Verfügbarkeit prüfen

Adjuvant Aromatase Inhibitors for Early Breast Cancer After Chemotherapy-Induced Amenorrhoea: Caution and Suggested Guidelines

Journal of clinical oncology, 2006-06, Vol.24 (16), p.2444-2447

2006

Link zum Volltext

Verfügbarkeit prüfen

Landscape of germline pathogenic variants in patients with dual primary breast and lung cancer

Human genomics, 2023-07, Vol.17 (1), p.66-66, Article 66

2023

Link zum Volltext

Verfügbarkeit prüfen

Breast cancer in women with neurofibromatosis type 1 (NF1): a comprehensive case series with molecular insights into its aggressive phenotype

Breast cancer research and treatment, 2018-10, Vol.171 (3), p.719-735

2018

Link zum Volltext

Verfügbarkeit prüfen

Issues and perspectives of drug development from Asia; a view from Singapore in breast cancer trials

Annals of oncology, 2018-10, Vol.29, p.vii4-vii4

Yap, Yoon-Sim

2018

Link zum Volltext

Verfügbarkeit prüfen

Correction: Landscape of germline pathogenic variants in patients with dual primary breast and lung cancer

Human genomics, 2023-08, Vol.17 (1), p.74-74, Article 74

2023

Link zum Volltext

Verfügbarkeit prüfen

Whole‐exome sequencing of breast cancer, malignant peripheral nerve sheath tumor and neurofibroma from a patient with neurofibromatosis type 1

Cancer medicine (Malden, MA), 2015-12, Vol.4 (12), p.1871-1878

2015

Link zum Volltext

Verfügbarkeit prüfen

Effects of housing value and medical subsidy on treatment and outcomes of breast cancer patients in Singapore: A retrospective cohort study

The Lancet regional health. Western Pacific, 2021-01, Vol.6, p.100065-100065, Article 100065

2021

Link zum Volltext

Verfügbarkeit prüfen

Exploiting metabolic vulnerabilities in breast cancers with NF1 loss

Cell reports. Medicine, 2023-04, Vol.4 (4), p.101010-101010, Article 101010

2023

Link zum Volltext

Verfügbarkeit prüfen

Elucidating therapeutic molecular targets in premenopausal Asian women with recurrent breast cancers

NPJ breast cancer, 2018-07, Vol.4 (1), p.19-7, Article 19

2018

Link zum Volltext

Verfügbarkeit prüfen

Contrasting Epidemiology and Clinicopathology of Female Breast Cancer in Asians vs the US Population

JNCI : Journal of the National Cancer Institute, 2019-12, Vol.111 (12), p.1298-1306

2019

Link zum Volltext

Verfügbarkeit prüfen

A Phase I Study of LSZ102, an Oral Selective Estrogen Receptor Degrader, with or without Ribociclib or Alpelisib, in Patients with Estrogen Receptor-Positive Breast Cancer

Clinical cancer research, 2021-11, Vol.27 (21), p.5760-5770

2021

Link zum Volltext

Verfügbarkeit prüfen

Patterns of relapse after neoadjuvant chemotherapy in breast cancer: implications for surveillance in clinical practice

Breast cancer research and treatment, 2019-08, Vol.177 (1), p.197-206

2019

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 139

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(136)
Mit Volltextzugriff
(130)

Publikationsform

Artikel
(138)
Webseiten
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

PI3K/Akt/mTOR inhibitors in breast cancer

Overall Survival with Ribociclib plus Letrozole in Advanced Breast Cancer

Everolimus for women with trastuzumab-resistant, HER2-positive, advanced breast cancer (BOLERO-3): a randomised, double-blind, placebo-controlled phase 3 trial

Ribociclib, a CDK 4/6 inhibitor, plus endocrine therapy in Asian women with advanced breast cancer

HER2 expression, copy number variation and survival outcomes in HER2-low non-metastatic breast cancer: an international multicentre cohort study and TCGA-METABRIC analysis

Potential value of ctDNA monitoring in metastatic HR + /HER2 - breast cancer: longitudinal ctDNA analysis in the phase Ib MONALEESASIA trial

Tissue-specific cell-free DNA degradation quantifies circulating tumor DNA burden

Classification of HER2-negative breast cancers by ERBB2 copy number alteration status reveals molecular differences associated with chromosome 17 gene aberrations

Low-dose anti-inflammatory combinatorial therapy reduced cancer stem cell formation in patient-derived preclinical models for tumour relapse prevention

Detection and prognostic relevance of circulating tumour cells (CTCs) in Asian breast cancers using a label-free microfluidic platform

Impact of deviation from guideline recommended treatment on breast cancer survival in Asia

An Overview of the Treatment Efficacy and Side Effect Profile of Pharmacological Therapies in Asian Patients with Breast Cancer

Regulatory and operational challenges in conducting Asian International Academic Trial for expanding the indications of cancer drugs

Adjuvant Aromatase Inhibitors for Early Breast Cancer After Chemotherapy-Induced Amenorrhoea: Caution and Suggested Guidelines

Landscape of germline pathogenic variants in patients with dual primary breast and lung cancer

Breast cancer in women with neurofibromatosis type 1 (NF1): a comprehensive case series with molecular insights into its aggressive phenotype

Issues and perspectives of drug development from Asia; a view from Singapore in breast cancer trials

Correction: Landscape of germline pathogenic variants in patients with dual primary breast and lung cancer

Whole‐exome sequencing of breast cancer, malignant peripheral nerve sheath tumor and neurofibroma from a patient with neurofibromatosis type 1

Effects of housing value and medical subsidy on treatment and outcomes of breast cancer patients in Singapore: A retrospective cohort study

Exploiting metabolic vulnerabilities in breast cancers with NF1 loss

Elucidating therapeutic molecular targets in premenopausal Asian women with recurrent breast cancers

Contrasting Epidemiology and Clinicopathology of Female Breast Cancer in Asians vs the US Population

A Phase I Study of LSZ102, an Oral Selective Estrogen Receptor Degrader, with or without Ribociclib or Alpelisib, in Patients with Estrogen Receptor-Positive Breast Cancer

Patterns of relapse after neoadjuvant chemotherapy in breast cancer: implications for surveillance in clinical practice

Suchergebnisse filtern